Showing results 66 to 85 of 88
< previous
next >
| Issue Date | Title | Author(s) |
| 15-Sep-2020 | Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19 | Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Karteris, E; Kyrou, I |
| 18-Jan-2021 | Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19 | Kyrou, I; Randeva, HS; Spandidos, DA; Karteris, E |
| 28-Mar-2022 | NUCB2/Nesfatin-1 Reduces Obesogenic Diet Induced Inflammation in Mice Subcutaneous White Adipose Tissue | Gharanei, S; Ramanjaneya, M; Patel, AH; Patel, V; Shabir, K; Auld, C; Karteris, E; Kyrou, I; Randeva, HS |
| 30-Apr-2021 | On the role of artificial intelligence in medical imaging of COVID-19 | Born, J; Beymer, D; Rajan, D; Coy, A; Mukherjee, VV; Manica, M; Prasanna, P; Ballah, D; Guindy, M; Shaham, D; Shah, PL; Karteris, E; Robertus, JL; Gabrani, M; Rosen-Zvi, M |
| 2015 | Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103 | Davies, J; Chen, J; Pink, R; Carter, D; Saunders, N; Sotiriadis, G; Bai, B; Pan, Y; Howlett, D; Payne, A; Randeva, H; Karteris, E |
| 9-Jul-2021 | A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer | Kerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E |
| 26-May-2020 | Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19 | Katopodis, P; Anikin, V; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E |
| 9-Jun-2017 | Perioperative detection of circulating tumour cells in patients with lung cancer | Chudasama, D; Burnside, N; Beeson, J; Karteris, E; Rice, A; Anikin, V |
| 2012 | Placental DEPTOR as a stress sensor during pregnancy | Mparmpakas, D; Zachariades, E; Goumenou, A; Gidron, Y; Karteris, E |
| 15-Jul-2020 | Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic | Kyrou, I; Karteris, E; Robbins, T; Chatha, K; Drenos, F; Randeva, HS |
| 15-Sep-2021 | Preclinical Studies on the Effect of Rucaparib in Ovarian Cancer: Impact of Brca2 Status | Saravi, S; Alizzi, Z; Tosi, S; Hall, M; Karteris, E |
| 1-Mar-2016 | The pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitro | Mankarious, A; Dave, F; Pados, G; Tsolakidis, D; Gidron, Y; Pang, Y; Thomas, P; Hall, M; Karteris, E |
| 2018 | Prognostic value of the DNA integrity index in patients with malignant lung tumors | Chudasama, DY; Aladag, Z; Felicien, MI; Hall, M; Beeson, J; Asadi, N; Gidron, Y; Karteris, E; Anikin, VB |
| 20-Apr-2018 | Prognostic value of the DNA Integrity Index in patients with malignant lung tumours | Karteris, E |
| 24-Feb-2022 | Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs | Kerslake, R; Randeva, HS; Jonigk, D; Werlein, C; Robertus, JL; Katopodis, P; Jasker, P; Spandidos, DA; Kyrou, I; Karteris, E |
| 3-Aug-2021 | The Role of the 3Rs for Understanding and Modeling the Human Placenta | Costa, J; Mackay, R; de Aguiar Greca, S-C; Corti, A; Silva, E; Karteris, E; Ahluwalia, A |
| 22-Jul-2021 | Statistical Meta-Analysis of Risk Factors for Endometrial Can cer and Development of a Risk Prediction Model Using an Artificial Neural Network Algorithm | Hutt, S; Mihaies, D; Karteris, E; Michael, A; Payne, A. M.; Chatterjee, J |
| 9-Jul-2019 | Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer | Karteris, E; Kumar, J; Murugaiah, V; Sotiriadis, G; Kaur, A; Jeyaneethi, J; Sturniolo, I; Alhamlan, F; Chatterjee, J; Hall, M; Kishore, U |
| 2015 | Surfactant proteins SP-A and SP-D modulate uterine contractile events in ULTR myometrial cell line | Sotiriadis, G; Dodagatta-Marri, E; Kouser, L; Alhamlan, FS; Kishore, U; Karteris, E |
| 2022 | Targeted complement activation therapy (TCAT) for cancer treatment | Doulami, Christiana |
